Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 452 for “"statin"”.

  1. Statin-induced muscle mitochondrial toxicity

    Statins are the mainstay of cholesterol-lowering therapy and are taken by millions of people worldwide. These drugs are generally well-tolerated but can cause myopathy ranging from mild muscle pain to fatal rhabdomyolysis. The mechanism of statin-induced myopathy (SIM) is not fully understood and …

    ubc Repository record for Statin-induced muscle mitochondrial toxicity (opens in a new tab) Download PDF for Statin-induced muscle mitochondrial toxicity (opens in a new tab)

  2. Genetic factors in statin intolerance

    … There are approximately 12 million statin users in the United Kingdom. Reports of statin intolerance occurs between 7 and 29% of users, manifesting as muscle ache, fatigue or more seriously, muscle breakdown leading to myopathy. Creatine phosphokinase (CK) levels are used as a …

    dundee Repository record for Genetic factors in statin intolerance (opens in a new tab) Download PDF for Genetic factors in statin intolerance (opens in a new tab)

  3. Statin influence on influenza mortality

    … pose significant public health threat. Statins are a class of medications traditionally used for atherosclerotic heart disease and elevated cholesterol. Though these medications have been very effective in managing these disease states, there is evidence that the drugs may also have …

    bu Repository record for Statin influence on influenza mortality (opens in a new tab)

  4. Statin mediated vasodilation in the vasculature.

    … A (HMG-CoA) reductase inhibitors (statins) in lowering cardiovascular morbidity and mortality in patients with and without coronary artery disease. Traditionally, the beneficial effects of statins have been ascribed entirely to their ability to lower serum cholesterol. Evidence …

    adelaide Repository record for Statin mediated vasodilation in the vasculature. (opens in a new tab)

  5. Persistence to statin treatment in lithuania /

    … lipoprotein (LDL) lowering medications such as statins play a huge role in the prevention and treatment of cardiovascular diseases. Statins have been shown to have a big impact in reducing the risk of major vascular events and mortality both in primary and secondary prevention. Despite the …

    vilnius Repository record for Persistence to statin treatment in lithuania / (opens in a new tab)

  6. Mitochondrial DNA alterations and statin-induced myopathy

    Background/Objectives: Statins are widely used to treat hyperlipidemia and lower cardiovascular disease risk. While statins are generally well tolerated, ~10-15% of patients experience statin-induced myopathy (SIM), a potentially fatal complication. Statin treatment has been associated with …

    ubc Repository record for Mitochondrial DNA alterations and statin-induced myopathy (opens in a new tab) Download PDF for Mitochondrial DNA alterations and statin-induced myopathy (opens in a new tab)

  7. Preclinical Potentiators of Statin-induced Anticancer Effects

    Statins have been used for decades in the treatment of hypercholesterolemic patients to decrease the incidence of adverse cardiovascular events. Statins target the rate-limiting enzyme of the mevalonate (MVA) pathway, 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR). Statin-mediated HMGCR …

    toronto-retro Repository record for Preclinical Potentiators of Statin-induced Anticancer Effects (opens in a new tab)

  8. Genome-wide association of statin-induced myopathy

    <p>Lowering LDL-cholesterol with statin therapy produces substantial reductions in cardiovascular events, and larger cholesterol reductions may produce larger benefits. Rarely, myopathy occurs with statins, especially at higher doses and in combination with certain medications. Similarly strong …

    oxford Restricted access

  9. Effect of statin treatment on preterm labour

    … aim to inhibit these inflammatory pathways. Statins, 5-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors, are potent inhibitors of cholesterol biosynthesis, which act on the mevalonate pathway. In addition to their lipid-lowering effects, statins also have anti-inflammatory …

    edinburgh Repository record for Effect of statin treatment on preterm labour (opens in a new tab)

  10. Mechanisms underlying statin-induced modulation of ryanodine receptors

    <p>Statins, a class of HMG-CoA reductase inhibitors, are amongst the most widely prescribed drugs for the treatment of elevated cholesterol. Despite their success, their use is associated with debilitating muscle side effects such a myopathy, myalgia and in the most serious cases, rhabdomyolysis. …

    oxford Repository record for Mechanisms underlying statin-induced modulation of ryanodine receptors (opens in a new tab)

  11. Established Statin Therapy and the Benefits of Niacin

    … if the addition of niacin to an established statin therapy would decrease residual cardiovascular risk. Key words used in multiple literature searches included the terms "dyslipidemias, Hydroxymethylglutaryl-CoA Reductase Inhibitors, cardiovascular diseases, niacin, cholesterol HDL, and …

    nodak Repository record for Established Statin Therapy and the Benefits of Niacin (opens in a new tab)

  12. POPULATION SOURCED DISCOVERY OF GENETIC VARIANTS IN STATIN METABOLISM

    … coenzyme A (HMG-CoA) reductase inhibitors, or statins, are one of the most prescribed drugs for the prevention of cardiovascular disease and act by reducing plasma low-density lipoprotein (LDL) cholesterol. In Singapore, 47% of adult patients use either atorvastatin or simvastatin. Statin …

    nus Repository record for POPULATION SOURCED DISCOVERY OF GENETIC VARIANTS IN STATIN METABOLISM (opens in a new tab) Download file for POPULATION SOURCED DISCOVERY OF GENETIC VARIANTS IN STATIN METABOLISM (opens in a new tab)

  13. Determinants of Statin Drug Sensitivity in Mevalonate-dependent Cancers

    Statins are widely prescribed cholesterol-lowering drugs that inhibit HMG-CoA reductase (HMGCR), the rate-limiting enzyme of the mevalonate pathway. Several lines of evidence support that certain tumours depend on the mevalonate pathway for growth and survival and are vulnerable to statins. …

    toronto-retro Repository record for Determinants of Statin Drug Sensitivity in Mevalonate-dependent Cancers (opens in a new tab)

  14. The significance of OATP and CYP450 in statin-flavonoid interactions

    Statins are the most prescribed drug world-wide as a first-line defence to hypercholesteraemia. In rare cases, statins can have adverse events such as myotoxicity which can further progress to a potentially fatal condition, rhabdomyolysis. This risk is exacerbated by drug-drug interactions between …

    adelaide Repository record for The significance of OATP and CYP450 in statin-flavonoid interactions (opens in a new tab)

  15. Aspirin and Statin Use for Primary Prevention of Cardiovascular Disease

    … mortality in the United States and aspirin and statins are well-known medications associated with CVD prevention. There are well-known benefits of aspirin for secondary prevention of CVD, but aspirin’s role in primary prevention remains controversial. The decision to start aspirin for primary …

    ndsu Repository record for Aspirin and Statin Use for Primary Prevention of Cardiovascular Disease (opens in a new tab)

  16. Post-Diagnosis Statin Use and Survival Among Patients with Cancer

    Statins are widely used cholesterol-lowering medications. Evidence from preclinical and observational studies suggest that statins use may improve cancer survival in patients with cancer, while findings from clinical trials have been mixed. The aim of this study was to evaluate the association …

    washington Repository record for Post-Diagnosis Statin Use and Survival Among Patients with Cancer (opens in a new tab)

  17. Body constitution, statin use, and tumor characteristics. Implications for prognosis.

    … and to examine the prognostic impact of statin use and body size changes in breast cancer patients. In paper I, we studied the prognostic impact of tumor-specific HMG-CoA reductase (HMGCR), the rate-limiting enzyme of the mevalonate pathway and the target of statin treatment, in breast …

    lund Repository record for Body constitution, statin use, and tumor characteristics. Implications for prognosis. (opens in a new tab) Download PDF for Body constitution, statin use, and tumor characteristics. Implications for prognosis. (opens in a new tab)

Page 1 of 23